STAT+: Merck, Isomorphic Labs partner to develop oncology drug candidates
Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.